GC Biopharma Corp.
KSC: 006280.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Eun-chul Huh
- Employees
- 2,009
- Headquarters
- Yongin-Si, South Korea
- IPO year
- 2000
- Market cap
- ₩1.6T
- Website
- https://www.gcbiopharma.com
Loading 006280…
Loading profile data…Frequently asked questions about 006280
What does GC Biopharma Corp. (006280.KS) do?
GC Biopharma Corp. engages in the manufacture and sale of pharmaceutical products. Its products include medicines for blood, over the counter drugs, generals, vaccines, and others. The company was founded on November 1, 1969 and is headquartered in Yongin, South Korea.
Where does 006280.KS trade?
GC Biopharma Corp. (006280.KS) trades on the Korea Exchange.
What sector is 006280.KS in?
GC Biopharma Corp. (006280.KS) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of GC Biopharma Corp.?
Eun-chul Huh is the chief executive officer of GC Biopharma Corp. (006280.KS).
Where is GC Biopharma Corp. headquartered?
GC Biopharma Corp. is headquartered in South Korea.
Does 006280.KS pay a dividend?
Yes — GC Biopharma Corp. (006280.KS) paid a trailing twelve-month dividend of KRW 1500.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 006280.KS go public?
GC Biopharma Corp. (006280.KS) completed its initial public offering in 2000.